Kimberly Irvine, CIP, CIM

Articles by Kimberly Irvine, CIP, CIM

Playing in the Sandbox--How Local Institutional Review Boards Can Happily Co-Exist with Central IRBs

July 9th 2013

Applied Clinical Trials

A recent paper published in PLOS ONE addresses research institutions? willingness ?or lack thereof?to defer to central institutional review boards for multicenter clinical trials.

Can a Central IRB Improve Efficiency?

ByKimberly Irvine, CIP, CIM

November 15th 2012

Academic Medical Centers as Study Sites: Tips for Success

ByKimberly Irvine, CIP, CIM

March 7th 2011

Applied Clinical Trials

Latest Updated Articles

Playing in the Sandbox--How Local Institutional Review Boards Can Happily Co-Exist with Central IRBs
July 9th 2013
Can a Central IRB Improve Efficiency?
November 15th 2012
Academic Medical Centers as Study Sites: Tips for Success
March 7th 2011

Kimberly Irvine, CIP, CIM

Articles by Kimberly Irvine, CIP, CIM

Playing in the Sandbox--How Local Institutional Review Boards Can Happily Co-Exist with Central IRBs

Can a Central IRB Improve Efficiency?

Academic Medical Centers as Study Sites: Tips for Success

Latest Updated Articles

Trending on Applied Clinical Trials Online

ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD

Why Payment Performance Has Become an Operational Brand for Sponsors: Q&A with Patrick Mizer, Ledger Run

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis